Analytical Data
-
Gene name
COLM
- Application
-
Alternative Names
GLDN; COLM; UNQ9339/PRO34011Gliomedin
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6ZMI3
-
Expression Region
1-551aa
-
AA Sequence
MARGAEGGRGDAGWGLRGALAAVALLSALNAAGTVFALCQWRGLSSALRALEAQRGREQREDSALRSFLAELSRAPRGASAPPQDPASSARNKRSHSGEPAPHIRAESHDMLMMMTYSMVPIRVMVDLCNSTKGICLTGPSGPPGPPGAGGLPGHNGLDGQPGPQGPKGEKGANGKRGKMGIPGAAGNPGERGEKGDHGELGLQGNEGPPGQKGEKGDKGDVSNDVLLAGAKGDQGPPGPPGPPGPPGPPGPPGSRRAKGPRQPSMFNGQCPGETCAIPNDDTLVGKADEKASEHHSPQAESMITSIGNPVQVLKVTETFGTWIRESANKSDDRIWVTEHFSGIMVKEFKDQPSLLNGSYTFIHLPYYFHGCGHVVYNNSLYYHKGGSNTLVRFEFGQETSQTLKLENALYFDRKYLFANSKTYFNLAVDEKGLWIIYASSVDGSSILVAQLDERTFSVVQHVNTTYPKSKAGNAFIARGILYVTDTKDMRVTFAFDLLGGKQINANFDLRTSQSVLAMLAYNMRDQHLYSWEDGHLMLYPVQFLSTTLNQ
-
Molecular Weight
58.9 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
COLM, short for collagen-like molecule, has garnered increasing attention in the realm of biomaterials and tissue engineering due to its unique structural and biochemical properties. Collagen, being the most abundant protein in mammals, plays a crucial role in maintaining the structural integrity of tissues. COLM, as a recombinant protein, is engineered to mimic the triple-helix structure of natural collagen, providing versatility in various applications such as wound healing, drug delivery, and scaffolding for tissue regeneration. The ability to produce COLM in controlled environments allows for the customization of molecular properties, enhancing its biocompatibility and functionality. Additionally, studies have shown that COLM promotes cell adhesion and proliferation, making it a promising candidate for regenerative medicine. This synthetic approach not only addresses the limitations of sourcing and purifying collagen from animal tissues but also offers a sustainable alternative for developing advanced biomaterials. Ongoing research aims to optimize COLM's mechanical properties and explore its potential in delivering therapeutic agents, with the ultimate goal of improving patient outcomes in clinical settings.











